english.prescrire.org > Topics > Advancing healthcare policy > The US experience

Advancing healthcare policy

Via its policy advocacy, Prescrire acts as a force for change in health policies, first and foremost in the interest of patients.

Advancing healthcare policy

Chronological recap of actions
Actions presented by theme

Direct-to-consumer advertising (DTCA) disguised as patient "information" [2007-2012] : The US experience

In the United States of America, direct-to-consumer advertising for prescription medicines is legal. With disatrous consequences in terms of public health.

DTCA: European Commission persists in putting industry's interests first (1/2013)
Revised proposals on "information" to patients: Still an open door to advertising (10/2011)
Towards DTC advertising for prescription drugs? The autumn will be crucial (continued) (11/2010)
Towards DTC advertising of prescription drugs in Europe? (7/2010)
Direct-to-consumer advertising of prescription drugs: harmful and difficult to regulate (1/2008)
Direct-to-consumer advertising for prescription drugs: abuse and confusion
In brief
A more ambitious strategy to improve access to relevant health information (7/2010)
Relevant health information: making the right choice for Europe (12/2009)
What is at stake, and our counterproposals
Actions
How to improve European citizens' access to independent and comparative health information (3/2010)
Influencing the public at large: the aim is to boost sales (7/2007)
The Legislative Process
The US experience
Back to the list of themes

Sitemap |
Terms of use |
Contact
|Top of page